2 3 Assay Advantage (Vaczine Analytics) Ltd 05807728 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of assay services. Digita Accounts Production Advanced 6.30.9574.0 true 05807728 2024-04-01 2025-03-31 05807728 2025-03-31 05807728 bus:OrdinaryShareClass1 2025-03-31 05807728 core:CurrentFinancialInstruments 2025-03-31 05807728 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 05807728 core:OfficeEquipment 2025-03-31 05807728 core:PlantMachinery 2025-03-31 05807728 bus:SmallEntities 2024-04-01 2025-03-31 05807728 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 05807728 bus:FilletedAccounts 2024-04-01 2025-03-31 05807728 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05807728 bus:RegisteredOffice 2024-04-01 2025-03-31 05807728 bus:CompanySecretaryDirector1 2024-04-01 2025-03-31 05807728 bus:Director2 2024-04-01 2025-03-31 05807728 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 05807728 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05807728 bus:Agent1 2024-04-01 2025-03-31 05807728 core:ComputerEquipment 2024-04-01 2025-03-31 05807728 core:OfficeEquipment 2024-04-01 2025-03-31 05807728 core:PlantMachinery 2024-04-01 2025-03-31 05807728 countries:EnglandWales 2024-04-01 2025-03-31 05807728 2024-03-31 05807728 core:OfficeEquipment 2024-03-31 05807728 core:PlantMachinery 2024-03-31 05807728 2023-04-01 2024-03-31 05807728 2024-03-31 05807728 bus:OrdinaryShareClass1 2024-03-31 05807728 core:CurrentFinancialInstruments 2024-03-31 05807728 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05807728 core:OfficeEquipment 2024-03-31 05807728 core:PlantMachinery 2024-03-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 05807728

Assay Advantage (Vaczine Analytics) Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Assay Advantage (Vaczine Analytics) Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

Assay Advantage (Vaczine Analytics) Ltd

Company Information

Directors | Dr Ranjev Savopoulos Dr John William Savopoulos

Company secretary | Dr Ranjev Savopoulos

Registered office | Warren House Bells Hill Bishop's Stortford Hertfordshire CM23 2NN

Accountants | Mansell & Co Chartered Certified Accountants5 Ducketts Wharf South Street Bishop Stortford Hertfordshire CM23 3AR

Assay Advantage (Vaczine Analytics) Ltd

(Registration number: 05807728)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 546 | 1,449
Investment property | 5 | 168,675 | 168,675
|  | 169,221 | 170,124
Current assets |  |  |
Debtors | 6 | 11,323 | 55,344
Cash at bank and in hand |  | 594,240 | 531,726
|  | 605,563 | 587,070
Creditors: Amounts falling due within one year | 7 | (88,543) | (87,560)
Net current assets |  | 517,020 | 499,510
Net assets |  | 686,241 | 669,634
Capital and reserves |  |  |
Called up share capital | 8 | 1,000 | 1,000
Retained earnings |  | 685,241 | 668,634
Shareholders' funds |  | 686,241 | 669,634

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 December 2025 and signed on its behalf by:

......................................... Dr Ranjev Savopoulos Company secretary and director

Assay Advantage (Vaczine Analytics) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Warren House
Bells Hill
Bishop's Stortford
Hertfordshire
CM23 2NN

These financial statements were authorised for issue by the Board on 3 December 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Assay Advantage (Vaczine Analytics) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Computer equipment | 3 years straight line
Office equipment | 3 years straight line

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Assay Advantage (Vaczine Analytics) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 3).

Assay Advantage (Vaczine Analytics) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4 | Tangible assets

| Plant and machinery £ | Office equipment £ | Total £
Cost or valuation
At 1 April 2024 | 2,077 | 1,676 | 3,753
Disposals | (107) | - | (107)
At 31 March 2025 | 1,970 | 1,676 | 3,646
Depreciation
At 1 April 2024 | 1,045 | 1,259 | 2,304
Charge for the year | 607 | 296 | 903
Eliminated on disposal | (107) | - | (107)
At 31 March 2025 | 1,545 | 1,555 | 3,100
Carrying amount
At 31 March 2025 | 425 | 121 | 546
At 31 March 2024 | 1,032 | 417 | 1,449

5 | Investment properties

| 2025 £
At 1 April | 168,675
At 31 March | 168,675

There has been no valuation of investment property by an independent valuer.

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 10,054 | 54,039
Other debtors | 1,269 | 1,305
| 11,323 | 55,344

Assay Advantage (Vaczine Analytics) Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 14,591 | 27,270
Accruals and deferred income | 2,334 | 1,980
Other creditors | 71,618 | 58,310
| 88,543 | 87,560

8 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary Shares of £1 each | 1,000 | 1,000 | 1,000 | 1,000